C07K 16/40
Against enzymes
Official title: against enzymes
C07K16/40 (Against enzymes) appears on 3,886 US grants and 6,282 published applications in this corpus.
Search patents in C07K- Granted patents
- 3,886
- Published applications
- 6,282
- Assignees
- 2,143
- Inventors
- 10,438
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 0 | 0 |
| 1986 | 6 | 0 |
| 1987 | 3 | 0 |
| 1988 | 5 | 0 |
| 1989 | 11 | 0 |
| 1990 | 14 | 0 |
| 1991 | 12 | 0 |
| 1992 | 14 | 0 |
| 1993 | 24 | 0 |
| 1994 | 26 | 0 |
| 1995 | 25 | 0 |
| 1996 | 27 | 0 |
| 1997 | 75 | 0 |
| 1998 | 85 | 0 |
| 1999 | 81 | 0 |
| 2000 | 72 | 0 |
| 2001 | 83 | 22 |
| 2002 | 70 | 110 |
| 2003 | 70 | 296 |
| 2004 | 58 | 129 |
| 2005 | 41 | 150 |
| 2006 | 103 | 173 |
| 2007 | 127 | 124 |
| 2008 | 82 | 127 |
| 2009 | 62 | 193 |
| 2010 | 92 | 197 |
| 2011 | 83 | 191 |
| 2012 | 91 | 179 |
| 2013 | 121 | 267 |
| 2014 | 145 | 330 |
| 2015 | 220 | 333 |
| 2016 | 199 | 440 |
| 2017 | 204 | 358 |
| 2018 | 202 | 314 |
| 2019 | 228 | 314 |
| 2020 | 201 | 316 |
| 2021 | 162 | 299 |
| 2022 | 189 | 297 |
| 2023 | 129 | 305 |
| 2024 | 173 | 315 |
| 2025 | 154 | 284 |
| 2026 | 112 | 219 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Aggrecan binding immunoglobulins6 Oct 2026US 12,753,224 B2Ablynx N. V.
- Use of LANCL1 and antibodies thereof as a diagnostic and therapeutic target for the management and treatment of cancer29 Sep 2026US 12,747,301 B2The University of Hong Kong
- Diagnosis, prognosis and treatment of malignant neoplasms29 Sep 2026US 12,748,114 B2Rhode Island Hospital
- Preparation comprising anti-PCSK9 antibody and use thereof22 Sep 2026US 12,741,023 B2Innovent Biologics (Suzhou) Co., Ltd.
- Inhibiting the RNA methyltransferase METTL3 or its interaction with EIF3H to suppress oncogene translation and tumorigenesis22 Sep 2026US 12,742,021 B2Children's Medical Center Corporation
- Fap-targeted antibody-drug conjugates8 Oct 2026US 2026/0306653 A1Oncomatryx Biopharma, S.L.
- Engineered Antibodies and Uses Thereof8 Oct 2026US 2026/0308277 A1Invitrogen Bioservices India Private Limited
- Antibody that binds to c3bbb8 Oct 2026US 2026/0308278 A1Hoffmann-La Roche Inc.
- Anti-nme antibody and method of treating cancer or cancer metastasis8 Oct 2026US 2026/0308282 A1Minerva Biotechnologies Corporation
- Compositions and methods for detection of aberrant cdk5 expression8 Oct 2026US 2026/0309712 A1Arizona Board of Regents on Behalf of the University of Arizona
Most cited
By later US patents
- Production of chimeric antibodies - a combinatorial approach1,367US 5,565,332 ACambridge Antibody Technology Limited · 1996
- Methods for producing members of specific binding pairs893US 5,969,108 ACambridge Antibody Technology Limited · 1999
- Methods for producing members of specific binding pairs849US 5,733,743 ACambridge Antibody Technology Limited · 1998
- Heterodimeric receptor libraries using phagemids677US 5,658,727 AThe Scripps Research Institute · 1997
- Monoclonal antibodies and detection methods for phosphinothricin-N-acetyl-transferase enzyme640US 9,371,394 B2Dow AgroSciences LLC · 2016